6 Pre-Transfusion Testing

Download as pdf or txt
Download as pdf or txt
You are on page 1of 24

PRE-TRANSFUSION TESTING

MTBT 2114 FUNDAMENTAL OF BLOOD TRANSFUSION

TERRY ANSLEM RIMPA


ILKKM KUCHING 2023
Learning objective
01 Understanding the purpose and importance of p
erforming pre transfusion testing

02 Understanding the steps in pre transfusion testi


ng

03 Understanding the management of issuing blood includin


g storage and transportation of blood to the ward

04 Understanding the management of returning bl


ood
Topic overview
Introduction
Pre-transfusion testing:
-a series of serologic and non serologic protocols
and testing procedure
-to ensure compatibility
-to prevent an immune mediated hemolytic t
ransfusion reaction
Request for testing
-first step
-the patient must give written informed consent prior
to transfusion
-consists of:
• Patient information (full name, id, test requested)
• Must be documented legibly
• History of previous transfusion
-repeat testing should not be requested if the patient
has current valid testing
Patient identification, sample collection and lab
elling
-specific policy and procedure for identification and labelling
(patient and donor)
-patient identification must be verified at the time of sample
collection (IC, passport, hospital registration number etc)
-don’t collect sample if:
• Inaccuracies detected
• Discrepancies
-use EDTA bottle or plain tube (depending on local policy)
-make sure the sample are free from hemolysis
-practice bed side labelling
Patient identification, sample collection and lab
elling

-clarify any transfusion history


-collect sample 96 hours prior to transfusion for:
• Patient who have recently transfused with the red cells
• Pregnant women within the previous 3 months
• Uncertain history patient
-repeat sample after 96 hours (to avoid possibility of new
antibody development in patients exposed to red cells ant
igens by transfusion or pregnancy)
Patient identification, sample collection and lab
elling
-for infants 4 months and below, collect 1.5 to 2.0ml blood
sample in EDTA tube and 3-5ml sample in EDTA from
the mother (single request)
-for infants older than 4 months, 3-5 ml of blood sample
should be taken in EDTA tube
-for elective case (plan for surgery etc, by appointment)
samples should be ready 24 hours before arrival EXCEPT for
rare blood group or Rh negative patient should be ready 5 days
before arrival
Determination of ABO
-to determine the patient’s correct ABO group
-should be carried twice, by 2 persons and from
different cell suspension
-the most critical pre-transfusion serologic test
-f irst step in determine matched donor before
proceed with compatibility test
-if the ABO forward and reverse grouping results
fail to give correct answer, additional testing must
be conducted to resolve the discrepancies
Determination of Rh D Group

-to determine the patient’s rhesus


-a critical test to determine either the patient’s
should be transfused with rhesus negative of r
hesus positive
-able to trigger antibody response after ABO blood
group
Crossmatching

-a routine test in blood transfusion lab


-a final check of ABO compatibility between donor
and patient
-may detect the presence of an antibody in the
patient’s serum that will react with antigens on the
donor red blood cells
-does not guarantee the safety of transfused blood
due to certain condition such as low incident antigen
or antibody
Crossmatching

The needs of the test:


-to choose the right donor to avoid transfusion r
eaction
-to detect irregular antibody in patient’s serum
-to detect any clerical error
-to maximized the benefit of the blood product
Crossmatching

-2 types of crossmatching:

a. Major-between donor’s red blood cells and p


atient’s serum
b. Minor- between patient’s red blood cells and d
onor serum
Crossmatching

-to detect as many clinically signif icant unexpected


antibodies as possible
-the recipient’s serum or plasma must be tested for
clinically unexpected antibodies
-detection of unexpected antibodies is important for
the selection of donor RBC that will have the best s
urvival rate in the patient’s circulation and to reduce
the risk of hemolytic transfusion reaction
Antibody screening
-a mandatory test for all requests for transfusion
-to detect antibody in red cells other than anti-A an
d anti-B (unexpected antibodies)
-will shortened the life span of red blood cells that
has been transfused
-records of previous transfusions shall be traced
-any discrepancy between current and previous
blood groups shall be fully investigated and
documented
Antibody screening

SCREENING CELLS
-commercially prepared
-consists of 2 or 3 cells
-derived from O cells (no anti-A and anti-B)
-donor red cell need to be phenotype to detect antige
n that might be clinically useful
Antibody screening

SCREENING CELLS

2 VIALS 3 VIALS
Antibody Identification

-shall be carried out for positive antibody screening


sample
-further test taken for any antibody identif ication th
at shows inconclusive result
Management of issuing blood
Management of issuing blood

MANAGEMENT OF RETURNING BLOOD

USED BLOOD BAG


-used blood bag and blood tag/ label that has been completely
filled up should be return to hospital blood bank within 24
hours
-the used blood bag must be kept for 7 days after transfusion
in proper storage
Management of issuing blood
COMPATIBILITY CARD/ LABEL SHALL CONTAIN THE
FOLLOWING INFORMATION

a. Name of hospital f. Date of transfusion


b. Ward g. Time transfusion starts and
c. Full name of recipient ends
d. IC/ Passport/ Hospital h. Volume transfused
e. Registration number i. Adverse transfusion
f. Recipient’s blood group reaction, if any
and Rh typing, age and gender j. Name and signature of staff
Management of issuing blood

MANAGEMENT OF RETURNING BLOOD

RETURN OF UNTRANSFUSED BLOOD


-should be return immediately to hospital blood bank
-untransfused blood shall be discarded unless it is kept in an
appropriate condition and temperature
-the ward shall inform the hospital blood bank if any
untransfused blood returned to the blood bank has not
complied with the storage or transportation temperature
Management of issuing blood

MANAGEMENT OF RETURNING BLOOD

BLOOD REMAINING FROM DISCONTINUED TRANSFUSION


-any blood remaining from a discontinued transfusion shall not
be used
-remnants of blood shall be clearly labelled as used blood and
returned to the hospital blood bank immediately
-details and reasons for discontinuing the transfusion shall be
clearly documented in the patient’s case notes
THANK YOU FOR LISTENIN
G

DON’T WATCH THE CLOCK, DO W


HAT IT DOES
KEEP GOING

You might also like